FDA Determines Regulatory Review Period for SYNERGY EVEROLIMUS-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM Patent Extension

Summary

The US Food and Drug Administration (FDA) has officially confirmed the regulatory review period for the SYNERGY EVEROLIMUS-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM, a medical device, in accordance with federal regulations, following a patent extension application submitted to the US Patent and Trademark Office (USPTO).